QT
AGN

Quantamental Technologies’s Allergan plc AGN Stock Holding History

Quantamental Technologies’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,700
Closed -$301K – 326
2020
Q1 		$301K Sell
1,700
-4,075
-71% -$767K 0.7% 55
2019
Q4 		$1.1M Buy
5,775
+4,551
+372% +$821K 0.57% 29
2019
Q3 		$206K Buy
+1,224
New +$199K 0.07% 491
2019
Q1 		– Sell
-502
Closed -$67K – 1924
2018
Q4 		$67K Buy
+502
New +$82.3K 0.04% 703

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Quantamental Technologies's AGN Position: Q2 2020 in Review

Quantamental Technologies sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,700 shares — an estimated $301K sold.

Quantamental Technologies first reported a position in AGN in Q4 2018 and held it in 4 quarters. The position peaked at $1.1M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Quantamental Technologies reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Quantamental Technologies sold 1,700 Allergan plc shares in Q2 2020, an estimated $301K.
  • Quantamental Technologies first reported a position in Allergan plc in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Allergan plc position peaked at $1.1M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Quantamental Technologies's 13F filing for Q2 2020, filed 14 Aug 2020.